Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
McKinsey
Argus Health
Moodys
Cipla
Medtronic
Colorcon
Chinese Patent Office
Mallinckrodt
Harvard Business School

Generated: October 18, 2017

DrugPatentWatch Database Preview

Claims for Patent: 5,674,872

« Back to Dashboard

Claims for Patent: 5,674,872

Title: Treatment of ovarian cancer
Abstract:A method of treating ovarian cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the water soluble camptothecin analog class.
Inventor(s): Johnson; Randall Keith (Ardmore, PA)
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Application Number:08/411,056
Patent Claims: 1. A method of treating ovarian cancer in a human afflicted therewith which comprises administering to such human an effective amount of a compound of the formula: ##STR3## wherein: a) X is hydroxy and R is trimethylammoniummethyl;

b) X is hydroxy and R is N-methylpiperazinylmethyl;

c) X is hydroxy and R is N-methylanilinomethyl;

d) X is hydroxy and R is cyclohexylaminomethyl;

e) X is hydroxy and R is N,N-dimethylaminoethyloxymethyl;

f) X is hydroxy and R is cyclopropylaminomethyl;

g) X is hydroxy and R is morpholinomethyl;

h) X is hydroxy and R is aminomethyl;

i) X is hydroxy and R is cyanomethyl; or

j) X is hydroxy and R is dimethylaminomethyl

or any pharmaceutically acceptable salts, hydrates and solyates thereof; wherein the course of therapy employed is from about 1.0 to about 2.5 mg/m.sup.2 of body surface area per day for about five consecutive days.

2. The method of claim 1 wherein the administration is oral.

3. The method of claim 1 wherein the administration is parenteral.

4. The method of claim 3 wherein the course of therapy employed is from about 1.5 to about 2 mg/m.sup.2 of body surface area per day for about five consecutive days.

5. The method of claim 4 wherein the course of therapy is repeated at least once at about a seven day to about a twenty-eight day interval.

6. The method of claim 3 wherein the administration is via short or long intravenous infusion.

7. The method of claim 6 wherein the administration is via a 30 minute intravenous infusion.

8. The method of claim 6 wherein the administration is via a 24 hour intravenous infusion.

9. The method of claim 6 wherein the compound is topotecan.

10. The method of claim 1 wherein the compound is topotecan.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Harvard Business School
Citi
Moodys
Fuji
Express Scripts
Healthtrust
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot